🔔Stock Alerts via Telegram — Free for All Users

CCLD Stock Risk & Deep Value Analysis

CareCloud Inc

Healthcare • Health Information Services

DVR Score

7.5

out of 10

Solid Pick

What You Need to Know About CCLD Stock

We analyzed CareCloud Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran CCLD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated Apr 18, 2026Run Fresh Analysis →

CCLD Risk Analysis & Red Flags

What Could Go Wrong

The company's future growth and market re-rating are highly dependent on successfully translating its AI automation and strategic partnerships into sustained, high *organic* revenue growth and significant FCF margin expansion. Failure to demonstrate consistent execution on these fronts, or if the market continues to primarily view its growth as acquisition-driven, could prevent the necessary re-rating and lead to the stock remaining undervalued, or even declining if forecasts are not met.

Risk Matrix

Overall

Moderate

Financial

Medium

Market

Low

Competitive

Medium

Execution

Medium

Regulatory

Medium

Red Flags

  • Significant past share dilution (approx. 26M shares issued via Preferred A conversion in 2025)

  • Historical negative revenue and earnings growth rates (prior to 2025 turnaround)

  • The cybersecurity incident in Q4 2025 highlights potential operational vulnerabilities, despite being resolved quickly.

Upcoming Risk Events

  • 📅

    Q1 2026 earnings miss or weak guidance

  • 📅

    Slower-than-expected organic growth rates

  • 📅

    Inability to achieve forecasted free cash flow generation

  • 📅

    Increased competitive pressure or pricing erosion in healthcare IT services

When to Reconsider

  • 🚪

    Exit if quarterly organic revenue growth falls below 5% YoY for two consecutive quarters.

  • 🚪

    Sell if free cash flow turns negative for two consecutive quarters, indicating a breakdown in financial health.

  • 🚪

    Re-evaluate if the company's P/S ratio consistently trades below 1.0x without clear explanations for deterioration.

Unlock CCLD Risk Analysis & Red Flags

Create a free account to see the full analysis

What Does CareCloud Inc (CCLD) Do?

Market Cap

$129.93M

Sector

Healthcare

Industry

Health Information Services

Employees

3,650

CareCloud, Inc., a healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. It also offers revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, therapists, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Visit CareCloud Inc Website

Investment Thesis

CareCloud represents a compelling high-risk, high-reward investment opportunity as an undervalued turnaround story in the rapidly evolving healthcare IT sector. With recent achievement of full-year profitability, strong forecasted free cash flow, strategic investments in AI-enabled RCM, and a low valuation relative to its growth potential and industry peers, the company is strategically positioned to capture significant market share and achieve a substantial re-rating as it demonstrates consistent organic growth and margin expansion, potentially delivering 10x returns within 3-5 years.

Is CCLD Stock Undervalued?

CareCloud Inc. (CCLD) has significantly strengthened its position since the last analysis, validating its turnaround narrative. The company reported a substantial beat on Q4 2025 revenue and EPS, achieving its first full-year positive EPS in 2025. Critically, strong positive operating and free cash flow are forecasted for 2026 and 2027, signaling a healthier financial trajectory. A new $50M credit facility bolsters liquidity, and a recent strategic partnership demonstrates execution on AI-enabled revenue cycle management. Valuation multiples remain below sector averages, suggesting undervaluation for a company with forecasted high EPS growth (45.5% per annum). While past dilution and acquisition-driven growth remain considerations, the clearer path to self-sustaining profitability and organic growth efforts through AI initiatives significantly de-risk the investment, supporting enhanced upside potential. The company's strategic positioning in the high-growth healthcare IT sector, coupled with improving fundamentals, underpins the elevated score and increased confidence in its 10x growth potential within 3-5 years.

Unlock the full AI analysis for CCLD

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

CCLD Price Targets & Strategy

12-Month Target

$9.50

Bull Case

$12.85

Bear Case

$3.10

Valuation Basis

15x EV/FCF on forecast FY26 FCF of $27M, divided by 42M shares outstanding.

Entry Strategy

Consider dollar-cost averaging near current levels ($3.07) or on dips towards the 52-week P/B median of $1.27 (implies price around $1.47, assuming current P/B is 2.64 is for $3.07, then 1.27/2.64 * $3.07 = $1.47) if market conditions allow, aiming to build a position below $4.00.

Exit Strategy

Take initial profits at $9.00-$10.00, reassess at $15.00. Implement a stop-loss order if the price falls below $2.50, representing a breach of recent consolidation levels and potential weakening of the turnaround narrative.

Portfolio Allocation

5% for moderate risk tolerance, up to 10% for aggressive portfolios.

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is CCLD Financially Healthy?

Valuation

P/E Ratio

12.03

Forward P/E

29.60

PEG Ratio

-0.23

Price/Book

0.79

Price/Sales

0.29

Profitability

Gross Margin

46.33%

Operating Margin

8.96%

Net Margin

8.48%

Return on Equity

18.98%

Revenue Growth

-15.98%

EPS

$0.29

Balance Sheet

Current Ratio

1.05

Quick Ratio

0.92

Debt/Equity

0.02

Cash Flow

EBITDA

$30.00M

Other

Beta (Volatility)

1.70

Does CCLD Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Expanding

Moat Sources

2 Identified

Switching CostsIntangible Assets/IP

The integration of EHR and RCM systems creates high switching costs for healthcare providers, making customers sticky. CareCloud's proprietary AI and specialized software for revenue cycle management contribute to intangible assets. Its established reputation in the mid-size practice segment further enhances durability, as healthcare organizations prefer trusted, integrated solutions. This moat is strengthening as they integrate more deeply with clients and refine AI offerings.

Moat Erosion Risks

  • Intense competition from larger, diversified healthcare IT providers and new innovative startups.
  • Rapid technological advancements requiring continuous R&D investment to maintain a competitive edge.
  • Potential for data breaches or service disruptions that could erode customer trust and reputation.

CCLD Competitive Moat Analysis

Sign up to see competitive advantages

CCLD Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral (Likely limited mainstream retail investor attention, but positive amongst those following the turnaround story.)

Institutional Sentiment

Positive (Zacks Rank #2 Buy, Value Grade A; suggests favorable view from a key institutional research provider).

Insider Activity (Form 4)

No specific insider transaction details (Form 4 filings) from the last 90 days are provided in the research brief.

Options Flow

Normal options activity (No specific unusual options activity or put/call ratio skew detailed in the research).

Earnings Intelligence

Next Earnings

2026-05-05 (Q1 2026)

Surprise Probability

High (Company significantly beat Q4 2025 estimates by 13.1% on revenue and 250% on EPS.)

Historical Earnings Pattern

Based on the significant beat for Q4 2025, the stock is likely to react positively to strong earnings beats and robust forward guidance. Past patterns for a turnaround company can be volatile.

Key Metrics to Watch

Organic revenue growth (beyond acquisition contribution)Free cash flow generation and margin expansionForward guidance for full-year 2026 EPS and revenueUpdate on AI initiative deployments and customer adoption

Competitive Position

Top Competitor

OMDA

Market Share Trend

Gaining (Implied by the turnaround, strategic acquisitions, and focus on expanding AI-enabled RCM services, particularly for mid-size practices).

Valuation vs Peers

Undervalued (Trading significantly below Healthcare Services industry averages on P/B ratio (2.64 vs. 5.76) and P/S ratio (1.01 vs. 1.44). EV/FCF suggests extreme undervaluation).

Competitive Advantages

  • Strong reputation and established presence among mid-size healthcare practices
  • Structured denial management workflows and transparent reporting dashboards
  • Strategic focus on AI-enabled revenue cycle management (RCM) solutions
  • Growth-by-acquisition strategy to expand service offerings and customer base

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive CCLD Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings (Expected May 5, 2026)
  • Nasdaq Closing Bell / Analyst Day (Expected May 2026)
  • Deployment and initial results from new AI-enabled RCM partnerships

Medium-Term (6-18 months)

  • Accelerated organic revenue growth beyond forecast 8.3%
  • Further strategic partnerships and customer wins
  • Successful integration and accretion from past acquisitions (e.g., Medsphere)
  • Expansion of gross and operating margins

Long-Term (18+ months)

  • Achieving market leadership in specific healthcare IT niches (e.g., AI-enabled RCM for mid-market practices)
  • Platform expansion and diversification of service offerings
  • Substantial re-rating of valuation multiples to align with high-growth SaaS peers
  • Potential uplisting to a major exchange if market cap grows significantly

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for CCLD?

  • Consistent acceleration in quarterly organic revenue growth rates.

  • Expansion of gross and operating margins, indicating improving operational efficiency.

  • Confirmation of sustained positive free cash flow, ideally exceeding current forecasts.

Bull Case Analysis

See what could go right with Premium

Competing with CCLD

See how CareCloud Inc compares to related companies

CompanyMarket CapDVR ScoreP/ERevenueProfit MarginRev Growth

CareCloud Inc

CCLD

$129.9M7.512.0$130.0M8.5%-16.0%

AbbVie Inc

ABBV

$403.8B0.1171.8Compare →

Johnson & Johnson

JNJ

1.0Compare →

Omada Health Inc

OMDA

$901.0M6.5-78.7-4.9%Compare →

Pfizer Inc

PFE

$150.6B0.219.4$62.6B12.4%-1.6%Compare →

UnitedHealth Group Inc

UNH

$276.2B0.322.9$113.7B2.7%1181.0%Compare →

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How CareCloud Inc Makes Money

CareCloud Inc. provides cloud-based software and tech-enabled services designed to modernize and optimize healthcare operations for physician practices, hospitals, and other healthcare organizations. The company helps its customers manage patient records, streamline administrative tasks, and most importantly, improve their financial health through efficient billing, claims processing, and denial management using advanced, often AI-enabled, revenue cycle management (RCM) solutions. This allows healthcare providers to focus more on patient care and less on complex back-office functions.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for CareCloud Inc (CCLD)?

As of April 18, 2026, CareCloud Inc has a DVR Score of 7.5 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of CareCloud Inc?

CareCloud Inc's market capitalization is approximately $129.9M. The company operates in the Healthcare sector within the Health Information Services industry.

What ticker symbol does CareCloud Inc use?

CCLD is the ticker symbol for CareCloud Inc. The company trades on the NGM.

What is the risk level for CCLD stock?

Our analysis rates CareCloud Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of CCLD?

CareCloud Inc currently has a price-to-earnings (P/E) ratio of 12.0. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

Is CareCloud Inc's revenue growing?

CareCloud Inc has reported revenue growth of -16.0%. Revenue has been declining, which warrants closer examination.

Is CCLD stock profitable?

CareCloud Inc has a profit margin of 8.5%. The company is profitable but margins are modest.

How often is the CCLD DVR analysis updated?

Our AI-powered analysis of CareCloud Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 18, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CCLD (CareCloud Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to CCLD Stock Risk & Deep Value Analysis